TTS PHARMA LIMITED

Dissolved United Kingdom

Wholesale of pharmaceutical goods

2 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goodsOther human health activities
T

TTS PHARMA LIMITED

Wholesale of pharmaceutical goods

Founded 15 Oct 2012 Dissolved United Kingdom 2 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goodsOther human health activities
Accounts Submitted 25 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 28 Sept 2025 Next due 12 Oct 2026 4 months remaining
Net assets £595K £594K 2024 year on year
Total assets £3M £161K 2024 year on year
Total Liabilities £2M £433K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Telephone

0800 000 0000

Website

www.example.com

Full company profile for TTS PHARMA LIMITED (08252177), a dissolved life sciences and medical technology company based in United Kingdom. Incorporated 15 Oct 2012. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£2.67k

Decreased by £160.02k (-98%)

Net Assets

£594.91k

Decreased by £593.90k (-50%)

Total Liabilities

£2.10M

Increased by £432.92k (+26%)

Turnover

N/A

Employees

2

Debt Ratio

78%

Increased by 20 (+34%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 2

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

11 Allotments 73,733,562 Shares £3.46m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Sept 20253,232,810£300k£0.093
2 Sept 20253,232,810£300k£0.093
2 Sept 20253,232,810£300k£0.093
17 May 202313,333,334£400k£0.03
12 Dec 202216,666,667£500k£0.03

Officers

Officers

1 active 2 resigned
Status
Blaney, Wilson CecilDirectorBritishUnited Kingdom5317 Nov 2022Active

Shareholders

Shareholders (35)

Tocafy Investments Ltd
84.8%
Karl Knoflach
5.2%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Paul Richard Atherton

British

Active
Notified 13 Mar 2019
Residence United Kingdom
DOB May 1965
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

TTS PHARMA LIMITED Current Company
ENDOPURE LTD united kingdom

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Sept 2025AddressChange Sail Address Company With Old Address New Address
28 Sept 2025CapitalAllotment of shares (GBP 6,788.9) on 2 Sept 2025
28 Sept 2025Confirmation StatementConfirmation statement made on 28 Sept 2025 with no updates
28 Sept 2025CapitalAllotment of shares (GBP 6,465.6197) on 2 Sept 2025
28 Sept 2025CapitalAllotment of shares (GBP 67,899.007) on 2 Sept 2025
30 Sept 2025 Address

Change Sail Address Company With Old Address New Address

28 Sept 2025 Capital

Allotment of shares (GBP 6,788.9) on 2 Sept 2025

28 Sept 2025 Confirmation Statement

Confirmation statement made on 28 Sept 2025 with no updates

28 Sept 2025 Capital

Allotment of shares (GBP 6,465.6197) on 2 Sept 2025

28 Sept 2025 Capital

Allotment of shares (GBP 67,899.007) on 2 Sept 2025

Recent Activity

Latest Activity

Change Sail Address Company With Old Address New Address

8 months ago on 30 Sept 2025

Allotment of shares (GBP 6,788.9) on 2 Sept 2025

8 months ago on 28 Sept 2025

Confirmation statement made on 28 Sept 2025 with no updates

8 months ago on 28 Sept 2025

Allotment of shares (GBP 6,465.6197) on 2 Sept 2025

8 months ago on 28 Sept 2025

Allotment of shares (GBP 67,899.007) on 2 Sept 2025

8 months ago on 28 Sept 2025